Pharmacokinetics of consecutive oral moxifloxacin (400 mg/day) in patients with respiratory tract infection

A population pharmacokinetic analysis was performed to investigate the pharmacokinetics of moxifloxacin (400 mg) following a once-daily oral administration in 28 patients with respiratory tract infection disease. The maximum plasma concentration and the area under the plasma concentration–time curve...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Ther Adv Respir Dis
Glavni autori: Ito, Fumitaka, Ohno, Yasushi, Toyoshi, Sayaka, Kaito, Daizo, Koumei, Yanase, Endo, Junki, Kamamiya, Fumihiko, Mori, Hidenori, Mori, Masahiro, Morishita, Megumi, Funaguchi, Norihiko, Minatoguchi, Shinya
Format: Artigo
Jezik:Inglês
Izdano: SAGE Publications 2015
Teme:
Original Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5933663/
https://ncbi.nlm.nih.gov/pubmed/26660898
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1753465815620338
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items